Heart Failure With Preserved Ejection Fraction: The Quest for a Blood Pressure Goal

J Am Coll Cardiol. 2020 Apr 14;75(14):1657-1658. doi: 10.1016/j.jacc.2020.02.024. Epub 2020 Mar 16.

Authors

Hector O Ventura¹, Carl J Lavie², Mandeep R Mehra³

Affiliations

¹ Department of Cardiology, Cardiomyopathy, and Heart Transplantation Center, Ochsner Clinic Foundation, New Orleans, Louisiana. Electronic address: hventura@ochsner.org.
² Department of Cardiology, Cardiomyopathy, and Heart Transplantation Center, Ochsner Clinic Foundation, New Orleans, Louisiana.
³ the Brigham Health Center for Advanced Heart Disease and Harvard Medical School, Boston, Massachusetts.

PMID: 32192800
DOI: 10.1016/j.jacc.2020.02.024

No abstract available

Keywords: blood pressure; heart failure hospitalization; heart failure with preserved ejection fraction; sacubitril/valsartan.

Publication types

Editorial
Comment

MeSH terms

Aminobutyrates
Biphenyl Compounds
Blood Pressure
Drug Combinations
Goals*
Heart Failure* / diagnosis
Heart Failure* / epidemiology
Heart Failure* / therapy
Humans
Stroke Volume
Tetrazoles
Valsartan

Substances

Aminobutyrates
Biphenyl Compounds
Drug Combinations
Tetrazoles
Valsartan
sacubitril and valsartan sodium hydrate drug combination